MedTrace Logo

Hidden Impairments During Subarachnoid Haemorrhage Recovery, Description and Evolution of a Newly Described Syndrom

NCT06276517 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2026-04-06

No results posted yet for this study

Summary

Descriptive observational study in patients with spontaneous subarachnoid hemorrhage or following aneurysmal rupture to assess the presence of a post-HSA syndrome at 3 months, 6 months and 1 year, and its impact on functional outcome using the Rivermead questionnaire

Conditions

  • Intracranial Hemorrhages

Interventions

OTHER

questionnaire

self-questionnaire with 16 questions, rated from 0 to 4, giving a total of 0 to 52 points.

OTHER

SS-QoL

49-question self-administered questionnaire covering 12 domains (including work/productivity, mood, social roles, family roles, personality, etc.).

OTHER

SF-36

multidimensional, generic scale, i.e. one that assesses health status independently of causal pathology, sex, age and treatment

OTHER

CIQ-R

16-question questionnaire with answers rated from 0 to 2 to assess Social reintegration

DIAGNOSTIC_TEST

BREFF

rapid frontal efficiency battery, 6 tests from 0 to 3 on each side

DIAGNOSTIC_TEST

MoCA

MoCA is a screening test for neurocognitive impairment. It comprises 11 categories scored from 0 to 6 for a total of 0 to 30 points.

OTHER

IADL

8 questions rated from 0 to 1 to assess functional outcome

OTHER

mMRS

mMRS score from 0 to 4 to assess functional outcome

OTHER

PCL-5

To assess the prevalence of post-traumatic stress using the PCL-5 self-questionnaire. PCL-5 is a 20-item self-administered questionnaire.

OTHER

Brief-Cope

28-question self-questionnaires to study patients' coping strategies

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-31
Primary Completion
2028-03-31
Completion
2028-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06276517 on ClinicalTrials.gov